Early Clinical Experience with Sutureless Aortic Valve Replacement for Severe Aortic Stenosis

Background: Sutureless aortic valve replacement (SU-AVR) has been developed as an alternative surgical treatment f or p atients with s ymptomatic s evere aortic stenosis ( AS). The aim o f this s tudy w as t o evaluate the clinical outcomes of SU-AVR through an assessment of hemodynamic performanc...

Full description

Bibliographic Details
Main Authors: Do Jung Kim, Hyo-Hyun Kim, Shin-Young Lee, Sak Lee, Byung-Chul Chang
Format: Article
Language:English
Published: Korean Society for Thoracic and Cardiovascular Surgery 2018-02-01
Series:Korean Journal of Thoracic and Cardiovascular Surgery
Subjects:
Online Access:http://www.kjtcvs.org/journal/download_pdf.php?doi=10.5090/kjtcs.2018.51.1.1
id doaj-6ab57e8a9c134b87be9ed1ae67015096
record_format Article
spelling doaj-6ab57e8a9c134b87be9ed1ae670150962020-11-24T21:03:52ZengKorean Society for Thoracic and Cardiovascular SurgeryKorean Journal of Thoracic and Cardiovascular Surgery2093-65162233-601X2018-02-015111710.5090/kjtcs.2018.51.1.1Early Clinical Experience with Sutureless Aortic Valve Replacement for Severe Aortic StenosisDo Jung KimHyo-Hyun KimShin-Young LeeSak LeeByung-Chul ChangBackground: Sutureless aortic valve replacement (SU-AVR) has been developed as an alternative surgical treatment f or p atients with s ymptomatic s evere aortic stenosis ( AS). The aim o f this s tudy w as t o evaluate the clinical outcomes of SU-AVR through an assessment of hemodynamic performance and safety. Methods: From December 2014 to June 2016, a total of 12 consecutive patients with severe AS underwent SU-AVR. The endpoints were overall survival and valve-related complications (paravalvular leakage, valve thrombosis, migration, endocarditis, and permanent pacemaker implantation). The mean follow-up duration was 18.1±8.6 months. Results: The mean age of the patients was 77.1±5.8 years and their mean Society of Thoracic Surgeons score was 9.2±17.7. The mean cardiopulmonary bypass and aortic cross-clamp times were 94.5±37.3 minutes and 54.9±12.5 minutes, respectively. Follow-up echocardiography showed good prosthesis function with low transvalvular pressure gradients (mean, 13.9±8.6 mm Hg and peak, 27.2±15.0 mm Hg) at a mean of 9.9±4.2 months. No cases of primary paravalvular leakage, valve thrombosis, migration, or endocarditis were reported. A new permanent pacemaker was implanted in 1 patient (8.3%). The 1-year overall survival rate was 83.3%±10.8%. Conclusion: Our initial experience with SU-AVR demonstrated excellent early clinical outcomes with good hemodynamic results. However, there was a high incidence of permanent pacemaker implantation compared to the rate for conventional AVR, which is a problem that should be solved.http://www.kjtcvs.org/journal/download_pdf.php?doi=10.5090/kjtcs.2018.51.1.1Aortic valve stenosisBioprosthesisHeart valve prosthesis implantation
collection DOAJ
language English
format Article
sources DOAJ
author Do Jung Kim
Hyo-Hyun Kim
Shin-Young Lee
Sak Lee
Byung-Chul Chang
spellingShingle Do Jung Kim
Hyo-Hyun Kim
Shin-Young Lee
Sak Lee
Byung-Chul Chang
Early Clinical Experience with Sutureless Aortic Valve Replacement for Severe Aortic Stenosis
Korean Journal of Thoracic and Cardiovascular Surgery
Aortic valve stenosis
Bioprosthesis
Heart valve prosthesis implantation
author_facet Do Jung Kim
Hyo-Hyun Kim
Shin-Young Lee
Sak Lee
Byung-Chul Chang
author_sort Do Jung Kim
title Early Clinical Experience with Sutureless Aortic Valve Replacement for Severe Aortic Stenosis
title_short Early Clinical Experience with Sutureless Aortic Valve Replacement for Severe Aortic Stenosis
title_full Early Clinical Experience with Sutureless Aortic Valve Replacement for Severe Aortic Stenosis
title_fullStr Early Clinical Experience with Sutureless Aortic Valve Replacement for Severe Aortic Stenosis
title_full_unstemmed Early Clinical Experience with Sutureless Aortic Valve Replacement for Severe Aortic Stenosis
title_sort early clinical experience with sutureless aortic valve replacement for severe aortic stenosis
publisher Korean Society for Thoracic and Cardiovascular Surgery
series Korean Journal of Thoracic and Cardiovascular Surgery
issn 2093-6516
2233-601X
publishDate 2018-02-01
description Background: Sutureless aortic valve replacement (SU-AVR) has been developed as an alternative surgical treatment f or p atients with s ymptomatic s evere aortic stenosis ( AS). The aim o f this s tudy w as t o evaluate the clinical outcomes of SU-AVR through an assessment of hemodynamic performance and safety. Methods: From December 2014 to June 2016, a total of 12 consecutive patients with severe AS underwent SU-AVR. The endpoints were overall survival and valve-related complications (paravalvular leakage, valve thrombosis, migration, endocarditis, and permanent pacemaker implantation). The mean follow-up duration was 18.1±8.6 months. Results: The mean age of the patients was 77.1±5.8 years and their mean Society of Thoracic Surgeons score was 9.2±17.7. The mean cardiopulmonary bypass and aortic cross-clamp times were 94.5±37.3 minutes and 54.9±12.5 minutes, respectively. Follow-up echocardiography showed good prosthesis function with low transvalvular pressure gradients (mean, 13.9±8.6 mm Hg and peak, 27.2±15.0 mm Hg) at a mean of 9.9±4.2 months. No cases of primary paravalvular leakage, valve thrombosis, migration, or endocarditis were reported. A new permanent pacemaker was implanted in 1 patient (8.3%). The 1-year overall survival rate was 83.3%±10.8%. Conclusion: Our initial experience with SU-AVR demonstrated excellent early clinical outcomes with good hemodynamic results. However, there was a high incidence of permanent pacemaker implantation compared to the rate for conventional AVR, which is a problem that should be solved.
topic Aortic valve stenosis
Bioprosthesis
Heart valve prosthesis implantation
url http://www.kjtcvs.org/journal/download_pdf.php?doi=10.5090/kjtcs.2018.51.1.1
work_keys_str_mv AT dojungkim earlyclinicalexperiencewithsuturelessaorticvalvereplacementforsevereaorticstenosis
AT hyohyunkim earlyclinicalexperiencewithsuturelessaorticvalvereplacementforsevereaorticstenosis
AT shinyounglee earlyclinicalexperiencewithsuturelessaorticvalvereplacementforsevereaorticstenosis
AT saklee earlyclinicalexperiencewithsuturelessaorticvalvereplacementforsevereaorticstenosis
AT byungchulchang earlyclinicalexperiencewithsuturelessaorticvalvereplacementforsevereaorticstenosis
_version_ 1716772672717717504